PineBridge Investments’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-208
| Closed | -$15K | – | 859 |
|
|
2023
Q2 | $15K | Buy |
+208
| New | +$15K | ﹤0.01% | 842 |
|
|
2018
Q4 | – | Sell |
-6,979
| Closed | -$1.2M | – | 1103 |
|
|
2018
Q3 | $1.2M | Buy |
6,979
+1,433
| +26% | +$245K | 0.02% | 547 |
|
|
2018
Q2 | $717K | Sell |
5,546
-276
| -5% | -$35.7K | 0.02% | 642 |
|
|
2018
Q1 | $600K | Sell |
5,822
-6,451
| -53% | -$665K | 0.01% | 664 |
|
|
2017
Q4 | $1.05M | Buy |
12,273
+8,112
| +195% | +$693K | 0.03% | 558 |
|
|
2017
Q3 | $353K | Buy |
4,161
+141
| +4% | +$12K | 0.01% | 746 |
|
|
2017
Q2 | $304K | Buy |
4,020
+51
| +1% | +$3.86K | 0.01% | 723 |
|
|
2017
Q1 | $262K | Buy |
3,969
+14
| +0.4% | +$924 | 0.01% | 750 |
|
|
2016
Q4 | $251K | Buy |
3,955
+87
| +2% | +$5.52K | 0.01% | 796 |
|
|
2016
Q3 | $246K | Buy |
3,868
+16
| +0.4% | +$1.02K | 0.01% | 441 |
|
|
2016
Q2 | $286K | Buy |
3,852
+301
| +8% | +$22.3K | 0.01% | 380 |
|
|
2016
Q1 | $237K | Sell |
3,551
-351
| -9% | -$23.4K | 0.01% | 428 |
|
|
2015
Q4 | $264K | Buy |
3,902
+255
| +7% | +$17.3K | 0.01% | 427 |
|
|
2015
Q3 | $194K | Buy |
3,647
+342
| +10% | +$18.2K | 0.01% | 525 |
|
|
2015
Q2 | $208K | Sell |
3,305
-4,091
| -55% | -$257K | 0.01% | 483 |
|
|
2015
Q1 | $356K | Buy |
7,396
+820
| +12% | +$39.5K | 0.01% | 546 |
|
|
2014
Q4 | $218K | Buy |
6,576
+29
| +0.4% | +$961 | 0.01% | 689 |
|
|
2014
Q3 | $192K | Buy |
6,547
+1,352
| +26% | +$39.6K | 0.01% | 663 |
|
|
2014
Q2 | $202K | Sell |
5,195
-3,000
| -37% | -$117K | 0.01% | 547 |
|
|
2014
Q1 | $344K | Sell |
8,195
-782
| -9% | -$32.8K | 0.01% | 558 |
|
|
2013
Q4 | $295K | Buy |
+8,977
| New | +$295K | 0.01% | 652 |
|